Berkshire Health Systems
  • Coronavirus Information Kiosk
  • Berkshire Patient Portal
  • COVID-19 Relief Fund for Berkshire Health Systems
  • Pay Your Bill Online
  • About Us
  • Employment
  • Medical Staff Portal
  • Coronavirus Information Kiosk
  • Berkshire Patient Portal
  • BMC Parking Maps
  • Advocacy for Access
  • Berkshire Patient Portal
  • BHS Blood Drawing Stations
  • BHS Bloodmobile
  • BHS Community Benefits Implementation Plan
  • BHS News
  • BHS Privacy Practices
  • BMC Community Benefits Report FY 2018
  • Fairview Hospital FY 2018 Community Benefit Report
  • BMC Medical Interpreters
  • Community Outreach Program
  • County Health Needs Assessment
  • Financial Counseling/Ayuda Financiera
  • Helpful Patient Tools
  • Medical Interpreters at Fairview
  • MedlinePlus
  • MedlinePlus en Espanol
  • One Medical Passport
  • Pay Your Bill Online
  • Pre-Surgical Assessment
  • Request a Medical Record
  • Send a Patient Greeting
  • Wellness Works Website - For BHS Employees & Spouses
  • Worksite Wellness
Berkshire Health Systems
  • Programs & Services
    • Addiction Services
    • Anesthesiology
    • Bariatrics
    • Better Start
    • Cancer Care
    • Cardiology
    • Concussion
    • Diabetes Care
    • Emergency Care
    • Endoscopy
    • Healthy Steps
    • Home Care
    • Hospitalists
    • Kidney & Dialysis
    • Laboratory Services
    • Maternity
    • Neurology
    • Neurosurgery
    • Occupational Med
    • Orthopedics
    • Outreach
    • Pain Management
    • Pharmacy
    • Psychiatry
    • Pulmonary Care
    • Radiology
    • Rehabilitation
    • Sleep Disorders
    • Sports Medicine
    • Stroke Care
    • Surgery
    • Trauma Care
    • Travel Medicine
    • Urgent Care
    • Urology
    • Wellness
    • WIC Program
    • Women's Imaging
    • Wound Care
    • Patient & Visitor Information
    • Quality Care & Patient Safety
    • Calendar & Events
    • News
    • Maps & Directions
    • Ways to Give
    • Health Encyclopedia
    • Berkshire Medical Center, Pittsfield, MA
    • Fairview Hospital, Great Barrington, MA
    • Berkshire Visiting Nurse Association
    • BHS Survey Module
  • Locations
    • Berkshire Medical Center
    • Fairview Hospital
    • North Adams Campus of BMC
    • BMC & Fairview Physician Practices
    • Berkshire Visiting Nurse Association
    • BHS Urgent Care
    • Long Term Care
    • BHS Laboratory - Blood Drawing Stations
  • Find a Physician
  • BHS Physician Practices
  • Medical Education
    • Message from Dr. Alex Sabo
    • Internal Medicine Residency
    • Surgery Residency
    • Osteopathic Medical Education
    • Psychiatry Residency
    • Dentistry Residency
    • Medical Students
    • Continuing Medical Education
    • School of Medical Technology
    • Schwartz Center Rounds
  • Coronavirus Information Kiosk
  • Berkshire Patient Portal
  • COVID-19 Relief Fund for Berkshire Health Systems
  • Pay Your Bill Online
  • About Us
  • Employment
  • Medical Staff Portal
RTOG 1005 -
  1. Home
  2. Clinical Trials

Clinical Trials

Principal Name   Harvey ZImbler, MD
Contact Name   Gloria Gero
Phone   (413) 496-8205
Alternate Phone   (413) 443-6000
Fax   (413) 443-2203
Title   RTOG 1005 - " A Phase III Trial of Accelerated Whole Breast Irradiation with Hypofractionation Plus Concurrent Boostr Versus Standard Whole Breast Irradiaiton Plus Sequential Boost for Early-Stage Breast Cancer"
Description   Primary Objective

To determine whether an accelerated course of hypofracionated WBI including a concomitant boost to the tumor bed in 15 fractions following lumpectomy will prove to be non-inferior in local control to a regimen of standard WBI with a sequential boost following lumpectomy for early-stage breast cancer patients.
Treatment   Oncology
Inclusion/Notes   ELIGIBILITY

- Pathologically proven diagnosis of breast cancer reescted by lumpectomy and whole breast irradiaiton with boost
without regional nodal irradiation planned
- The patient must be female
- pStage I, II Breast Cancer AND at least one of the following:
Age <50 years
Positive axillary nodes
Lymphovascular space invasion
' More than 2 close resection margins (>0 mm to <2 mm)
1 close resection maragin and extensive in-situ compnnet (EIC)
Focally positive rescetion margins
Non-hormone sensitive breast cancer (ER and PR-negative)
Grade III histology
Oncotype recurrence score >25
- pStage 0 breast cancer with nuclear grade 3 DCIS and patient age <50 years
- ypStage 0, I, II breast cancer resected by lumpectomy after neoadjuvant systemic therapy
- Study entry must be within 42 days of last breast /axillary surgery and/or last chemotherapy
- If multifocal brast cancer, then it must have been resected through a single lumpectomy incision with negative
margins
- Breast -conserving surgery with margins defined as follows:
Negative margins defined as no tumor at resected specimen edge
Close resection margins >0 mm to < 2mm
A focally positive resection margin
- Age > 18
- CT-imaging of the ipsilateral breast within 28 days of study entry for the radiation treatmnet planning.
- Appropriate stage for procotol entry, including no clinical evidence for distant metastases based upon the following
minimum diagnostic work up:
H&P examination , including breast exam and documentaiton of weight and Zubrod Performance Status of 0-2
within 28 days prior to study entry:
Bilateral mammogram within 6 months prior to study entry
- CBC/differential obtained within 14 days prior to study entry, with adequate bone marrow function defined as
follows:
ANC >1800 cell/mm3
Platelets >75,000 cell/mm3
Hemoglobin >8.0 g/dl
- Women of childbearing potential must have a negative serum pregnancy test wihtin 14 days of study entry
- Women of childbearing potential must be non-pregnant and non-lactating and willing to use medically acceptable
form of contraception during radiation therapy
- Patient must provide study specific informed consent prior to study entry

INELIGIBILTY
- AJCC Pathologic T4,N2or N3, or M1 breast cancer
- Treatment plan that includes regioal node irradiaiton
- Prior invasive non-breast malignancy unless disease free for a minimu of 5 years prior to registration
- Two or more breast cancers not resectaboe through a single lumpectomy incision
- DCIS and age >50 years
- DCIS and age < 50 years and nuclear grade 1 or 2
- Invasive breast cancer and low risk for 5-year in brest recurrence after lumpectomy with negative margins
- Unable to delineate on CT scan the extent of the target lumpectomy cavity for boost
- Suspicious unresected microcalicification, densities, or palpable abnormalities unless biopsied and found to be
benign
- Non-epithelial breast malignancies such as sarcoma or lymphoma
- Pagets disease of the nipple
- Male breast cancer
- Prior radiotherapy to the breast or prior radiation to the region of the ipsilateral breast that would result in
overlap of radiaiton therapy fields
- Intention to administer concurrent chemotherapy for current breast cancer
- Severe, active co-morbidity
- Pregnancy or women of childbearing potential who are sexually active and not willing/able to use medically
acceptable forms of contraception
- Active systemic Lupus, erythematosus, or any history of scleroderma, dermatomyositis with active rash
- Medical, psychiatric or other condition that would prevent the pateitn from receiving the protocol therapy or
providing informed consent.

Status   accruing
Current Trial Type   treatment
  •   (413) 447-2000
  •   Email - General Inquiries Only
  •   Email - BMC Patient Experience
  •   Email - BHS Physician Practices
  •   Email - Fairview Hospital Inquiries
  • Employment at BHS
  • About Us
  • 2018 BMC Report on Cancer
  • Quality Care & Patient Safety
  • Berkshire Patient Portal
  • Awards & Accreditations
  • BHS Community Outreach
  • BHS Bloodmobile
  • BMC FY 2018 Community Benefits Report
  • Fairview FY 2018 Community Benefits Report
  • Ways to Give
  • Give Us Your Feedback

© 2021 Berkshire Health Systems

725 North Street

Pittsfield, MA 01201

  • News
  • Privacy Practices
  • Practicas De Privacidad
  • Site Map
  • BHS Privacy Practices
  • Contact Us